The best indicator for Booking Holdings (BKNG)
We backtested 20 indicators across daily, weekly and hourly charts on real Booking Holdings (BKNG) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
Donchian Midline
On the weekly chart, this is the strongest risk-adjusted edge we found for Booking Holdings (BKNG) over ~27.3 years — beating buy-and-hold by 8.6% CAGR.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | Donchian Midline ✓ | Weekly | 16.9% | 0.61 | -57.1% | 43.9% | 66 | 8.6% |
| 2 | Bollinger Breakout | Weekly | 13.9% | 0.58 | -49.1% | 45.8% | 24 | 5.6% |
| 3 | EMA 50/200 Cross ✓ | Daily | 13.3% | 0.55 | -81.8% | 43.8% | 16 | 5.1% |
| 4 | EMA-10 Trend ✓ | Weekly | 11.8% | 0.48 | -69.9% | 41.5% | 118 | 3.5% |
| 5 | RSI Trend (>50) ✓ | Daily | 10.7% | 0.45 | -67.7% | 37.3% | 359 | 2.5% |
| 6 | Rate of Change | Weekly | 9.1% | 0.41 | -75.6% | 46.1% | 89 | 0.8% |
| 7 | EMA 20/50 Cross | Daily | 8.3% | 0.4 | -78.8% | 32.8% | 61 | 0.1% |
| 8 | RSI Trend (>50) ✓ | Weekly | 7.7% | 0.39 | -75.1% | 41.3% | 75 | -0.6% |
| 9 | ADX / DMI ✓ | Weekly | 7.2% | 0.39 | -77.7% | 44.1% | 34 | -1.0% |
| 10 | Donchian Breakout ✓ | Weekly | 7.7% | 0.39 | -68.1% | 45.5% | 22 | -0.5% |
| 11 | EMA 20/50 Cross ✓ | Weekly | 12.2% | 0.53 | -72.0% | 45.5% | 11 | 3.9% |
| 12 | SMA 50/200 Cross ✓ | Daily | 7.3% | 0.38 | -87.6% | 44.4% | 18 | -0.9% |
| 13 | MACD | Weekly | 7.8% | 0.38 | -84.7% | 43.1% | 58 | -0.5% |
| 14 | Rate of Change ✓ | Daily | 7.0% | 0.37 | -71.1% | 41.9% | 422 | -1.2% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Booking Holdings (BKNG), Donchian Midline on the weekly timeframe gave the best balance of return and risk in our test. It beat buy-and-hold — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.